BGI Genomics announced that based on the subscription results from the inquiry on September 15, 2025, the preliminary transfer price for the company's shareholder, Shenzhen BGI Genomics Technology Co., Ltd., is RMB 44.1 per share. This inquiry transfer is a private sale, not conducted through a centralized auction or block trade, and does not constitute a reduction in holdings in the secondary market. The transferee cannot transfer the shares acquired through the inquiry transfer within six months of the acquisition. The transferee of this inquiry transfer is an institutional investor with appropriate pricing power and risk tolerance.